Atrash, Shebli, US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, United States
-
Vol. 12, No. 1, Feb 2023 - Original Article
Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone
Abstract HTML PDF